63392 Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 

ANNUALIZED BURDEN TABLE

Respondents Number of

respondents 

Number of

responses/respondent 

Average

burden/

response

(in hrs) 

Family Core (adult family member) ............................................................................................. 39,000 1 24/60 

Adult Core (sample adult) ............................................................................................................ 32,000 1 18/60 

Adult Topical Module (sample adult) ........................................................................................... 32,000 1 18/60 

Child Core (adult family member) ............................................................................................... 13,000 1 16/60 

Child Topical Module (adult family member) ............................................................................... 13,000 1 6/60 

Re-interview Survey ..................................................................................................................... 3,250 1 5/60 

Dated: October 25, 2004. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention.

[FR Doc. 04–24321 Filed 10–29–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Grants for Dissertation Awards for 

Doctoral Candidates for ViolenceRelated and Unintentional Injury 

Prevention Research in Minority 

Communities 

Announcement Type: New. 

Funding Opportunity Number: CE05–

025. 

Catalog of Federal Domestic 

Assistance Number: 93.136. 

Key Dates: 

Letter of Intent Deadline: December 1, 

2004. 

Application Deadline: January 31, 

2005. 

I. Funding Opportunity Description

Authority: This program is authorized 

under section 301 (a) [42 U.S.C. 241(a)] of the 

Public Health Service Act, and section 391 

(a)[42 U.S.C. 280 b (a)] of the Public Service 

Health Act, as amended.

Purpose: The purposes of the program 

are to: 

• Solicit research applications that 

address the priorities reflected under 

the heading, ‘‘Research Objectives’’. 

• Build the scientific base for the 

prevention and control of injuries, 

disabilities, and deaths 

disproportionately experienced in 

minority communities. 

• Encourage doctoral candidates from 

a wide spectrum of disciplines, 

including epidemiology, medicine, 

biostatistics, public health, law and 

criminal justice, behavioral, and social 

sciences to perform research in order to 

prevent and control injuries more 

effectively. 

• Assist students in the completion of 

their dissertation research on a violencerelated or unintentional injury topic. 

• Encourage investigators to build 

research careers related to the 

prevention of violence-related or 

unintentional injuries, disabilities, and 

deaths in minority communities. 

This program addresses the ‘‘Healthy 

People 2010’’ focus area of Injury and 

Violence Prevention. 

A dissertation represents the most 

extensive research experience 

formulated and carried out by a doctoral 

candidate, with the advice and guidance 

of a mentor (the chair or another 

member of the dissertation committee). 

Dissertation research involves a major 

investment of the doctoral student’s 

time, energy, and interest and its 

substance is often the basis for 

launching a research career. This 

research initiative is aimed at providing 

students with assistance to complete 

their dissertation research on a violencerelated or unintentional injury topic 

and, thereby, increasing representation 

of junior investigators in violencerelated or unintentional injury research. 

Injuries are the number-one killer of 

children and young adults in the United 

States. They are the leading cause of 

years of potential life lost before age 65. 

More than five million people in the 

U.S. report suffering from chronic, 

injury-related disabilities, and the lives 

of millions of others have been 

dramatically affected by injuries to 

themselves or someone they love. 

Funding for research to prevent these 

injuries falls into two categories: 

violence prevention, and the prevention 

of unintentional injury.

Violence 

Deaths and injuries associated with 

interpersonal violence and suicidal 

behavior are a major public health 

problem in the United States and 

around the world. In 1999, more than 

46,000 people died from homicide and 

suicide in the United States. Among 15 

to 24 year olds, homicide and suicide 

rank as the second and the third leading 

causes of death. Violent deaths are the 

most visible consequence of violent 

behavior in our society. Morbidity 

associated with physical and emotional 

injuries and disabilities resulting from 

violence, however, also constitutes an 

enormous public health problem. For 

every homicide that occurs each year 

there are more than 100 non-fatal 

injuries resulting from interpersonal 

violence. For every completed suicide it 

is estimated that there are 20 to 25 

suicide attempts. The mortality and 

morbidity associated with violence are 

associated with a variety of types of 

violence including child mistreatment, 

youth violence, intimate partner 

violence, sexual violence, elder abuse, 

and self-directed violence or suicidal 

behavior. 

Violence has a disproportionate 

impact on racial and ethnic minorities. 

In 1999, homicide was the leading cause 

of death for African Americans and the 

second leading cause of death for 

Hispanics between the ages of 15 and 

34. Suicide was the second leading 

cause of death for American Indians and 

Alaskan Natives and Asian and Pacific 

Islanders 15 to 34 years of age. It is 

important to note that existing research 

indicates that race or ethnicity, per se, 

is not a risk factor for violent 

victimization or a cause of violent 

behavior. Rather, racial or ethnic status 

is associated with many other factors 

that do influence the risk of becoming 

a victim or behaving violently. As a 

result, racial and ethnic minorities in 

the United States experience high rates 

of both violent victimization and 

perpetration. A better understanding of 

the factors that contribute to this 

vulnerability or protection from such 

risk is important to furthering effective 

violence prevention programs that 

address racial and ethnic minorities. 

Unintentional Injury 

Unintentional injuries are a leading 

cause of death for Americans of all ages, 

regardless of gender, race, or economic 

status. Unintentional injuries are the 

leading cause of death for persons ages 

1–34 years, and the fifth leading cause 

of death overall. Nearly 100,000 people 

Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 63393

die each year as a result of unintentional 

injury. In fact, on average, every six 

minutes someone in the U.S. dies from 

causes such as motor vehicle crashes, 

falls, poisonings, drownings, fires, 

bicycle crashes, suffocation, or 

pedestrians being struck by motor 

vehicles. Millions of Americans also 

experience nonfatal unintentional 

injuries each year. Approximately one 

in ten people a year experience a 

nonfatal injury serious enough to 

require a visit to an emergency 

department. 

Although everyone is vulnerable to 

injury, some groups are at higher risk for 

unintentional injuries than others. For 

example, among all ethnic groups in the 

U.S., American Indians/Alaska Natives 

have the highest unintentional injury 

death rate (i.e., 61 per 100,000 

population compared with 41 per 

100,000 for African Americans and 36 

per 100,000 for Whites). African 

American children from birth through 

nine years have unintentional injury 

death rates almost twice as high as those 

of White children. Hispanic teenagers 

have higher motor vehicle occupant 

death rates than African American or 

White teenagers after adjusting for 

amount of travel. 

There is a critical need for highly 

qualified scientists to carry out research 

on violence and unintentional injury 

that can help in the development, 

implementation, and evaluation of 

effective injury prevention programs. In 

particular, scientists are needed who 

bring an understanding and sensitivity 

to the problems of violence and 

unintentional injury as they affect 

minority communities. The purpose of 

this extramural research training grant 

program is to attract young scientists to 

the field of injury prevention by 

encouraging doctoral candidates from a 

variety of disciplines to conduct 

violence and unintentional injury 

prevention research and hopefully carry 

this focus on throughout their careers. 

The number of individuals, who are 

members of minority groups, and who 

are engaged in injury-related prevention 

research, is currently small. This 

research program should also attract 

young minority scientists to the field of 

violence and unintentional injury 

prevention research. 

Measurable outcomes of the program 

will be in alignment with one (or more) 

of the following performance goal(s) for 

the National Center for Injury 

Prevention and Control (NCIPC): 

• Increase the capacity of injury 

prevention and control programs to 

address the prevention of injuries and 

violence.

• Monitor and detect fatal and nonfatal injuries. 

• Conduct a targeted program of 

research to reduce injury-related death 

and disability. 

Research Objectives 

Applicants are encouraged to propose 

studies that can feasibly be completed 

within the available funds and funding 

period. Proposed research for this 

Program Announcement must address 

one of the following research priorities 

in a minority community. Applications 

that fail to address these topics will be 

deemed nonresponsive. 

Violence Related Injury 

Any research priority listed in 

following chapters from NCIPC’s 

research agenda: Preventing Intimate 

Partner Violence, Sexual Violence, and 

Child Maltreatment, Preventing Suicidal 

Behavior, or Preventing Youth Violence. 

NCIPC’s research agenda can be 

accessed online at the following 

address: http://www.cdc.gov/ncipc/pubres/research_agenda/agenda.htm.

Unintentional Injury 

Any research priority listed in 

following chapters from NCIPC’s 

research agenda; Preventing Injuries at 

Home and in the Community, 

Preventing Injuries in Sports, 

Recreation, and Exercise, or Preventing 

Transportation Injuries. NCIPC’s 

research agenda can be accessed online 

at the following address: http://

www.cdc.gov/ncipc/pub-res/

research_agenda/agenda.htm.

Rigorous evaluations are needed to 

determine the effectiveness of 

interventions, programs, and policies 

addressing the prevention of violence. 

Experimental designs are strongly 

encouraged. However, NCIPC will 

consider other evaluation designs, if 

justified, as required by the needs and 

constraints in a particular setting. 

For effective interventions, it is 

possible to do cost-effectiveness studies. 

To be comparable to other cost 

effectiveness studies, they should follow 

the guidelines in the following 

references: Gold MR, Siegel JE, Russell 

LB, Weinstein MC. Cost-effectiveness in 

Health and Medicine. New York: Oxford 

University Press, 1996. Haddix AC, 

Teutsch SM, Corso, PS. Prevention 

Effectiveness: A Guide to Decision 

Analysis and Economic Evaluation. 

Second Edition. New York: Oxford 

University Press, 2003. 

For randomized trials, applicants are 

encouraged to clearly state how study 

subjects, whether individuals or groups, 

were selected, randomized, and 

followed through the trial. One relevant 

useful guidance document is Moher D, 

Schulz KF, Altman D. The CONSORT 

Statement, JAMA 2001; 285:1987–2001. 

II. Award Information 

Type of Award: Grant. 

Mechanism of Support: R49. 

Fiscal Year Funds: 2005. 

Approximate Total Funding:

$125,000. (This amount is an estimate, 

and is subject to availability of funds.) 

Approximate Number of Awards: Five 

(four awards will be made in the area of 

violence prevention research and 1 

award will be made in the area of 

unintentional injury prevention 

research). 

Approximate Average Award: $ 

25,000. (This amount includes both 

direct and indirect costs.) 

Floor of Award Range: None. 

Ceiling of Award Range: $ 25,000. 

(This amount includes both direct and 

indirect costs.) 

Anticipated Award Date: August 30, 

2005.

Budget Period Length: 12 months. 

Project Period Length: One year. 

III. Eligibility Information 

III.1. Eligible applicants 

Assistance will be provided to any 

United States public or private 

institution. The institution must support 

an accredited doctoral level training 

program. The performance site must be 

domestic. 

III.2. Cost Sharing or Matching 

Matching funds are not required for 

this program. 

III.3. Other 

If you request a funding amount 

greater than the ceiling of the award 

range, your application will be 

considered non-responsive, and will not 

be entered into the review process. You 

will be notified that your application 

did not meet the submission 

requirements. 

Eligible applicants may enter into 

contracts, including consortia 

agreements, as necessary to meet the 

requirements of the program and 

strengthen the overall application. 

A dissertation research training grant 

may not be transferred to another 

institution, except under unusual and 

compelling circumstances (such as if the 

mentor moves to a new institution and 

both the mentor and the applicant wish 

to move together). 

The responsible program official for 

CDC must be informed if there is a 

change of a mentor. A biographical 

sketch of the new mentor must be 

provided for approval by the CDC 

program official. 

63394 Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 

Two copies of the completed 

dissertation, including abstract, must be 

submitted to the CDC program official 

and will constitute the final report of 

the grant. The dissertation must be 

officially accepted by the dissertation 

committee or university official 

responsible for the candidate’s 

dissertation and must be signed by the 

responsible university official.

Any publications directly resulting 

from the grant should be reported to the 

CDC program official. The grantee also 

should cite receiving support from the 

NCIPC and CDC, both in the dissertation 

and any publications directly resulting 

from the dissertation-training grant. 

It is especially important that the 

abstract of your grant application 

(Description, PHS 398 form page 2) 

reflects the project’s focus, because the 

abstract will be used to help determine 

the responsiveness of the application. 

Special Requirements 

If your application is incomplete or 

non-responsive to the requirements 

listed in this section, it will not be 

entered into the review process. You 

will be notified that your application 

did not meet submission requirements. 

• Late applications will be considered 

non-responsive. See section ‘‘IV.3. 

Submission Dates and Times’’ for more 

information on deadlines. 

• Grant applications must 

demonstrate an overall match between 

the applicant’s proposed theme and 

research objectives and the program 

priorities as described under the 

heading, ‘‘Research Objectives.’’

• Applications must demonstrate 

effective and well-defined working 

relationships within the performing 

organization and with outside entities, 

which will ensure implementation of 

the proposed activities.

• Note: Title 2 of the United States Code 

Section 1611 states that an organization 

described in Section 501(c)(4) of the Internal 

Revenue Code that engages in lobbying 

activities is not eligible to receive Federal 

funds constituting an award, grant, or loan.

Individuals Eligible To Become 

Principal Investigators 

• The doctoral candidate must be the 

designated principal investigator. The 

principal investigator will be 

responsible for planning, directing, and 

executing the proposed project with the 

advice and consultation of the mentor 

and dissertation committee. 

• Applicants must be students in 

good standing enrolled in an accredited 

doctoral degree program. 

• The applicant must have the skill 

and academic training to conduct the 

proposed research and have the 

authority and responsibility to carry out 

the proposed project. 

• To receive this funding, applicants 

must have successfully defended their 

dissertation proposal. This must be 

verified in a letter of certification from 

the mentor (the chair or another member 

of the dissertation committee). CDC 

requests that if available, the letter of 

certification be submitted with the grant 

application, or before the negotiation 

and award. 

• Applicants must be conducting or 

intending to conduct research in one of 

the areas described under the ‘‘Research 

Objectives’’ in the Program 

Requirement’s section of this 

announcement. 

• The ability of the principal 

investigator to carry out injury control 

research projects as defined under 

Attachment 1 of this program 

announcement. The attachment is 

posted along with this announcement 

on the CDC Web site: http://

www.cdc.gov/ncipc/ncipchm.htm.

Applications, which do not meet the 

above requirements, will be considered 

non-responsive. 

Any individual with the skills, 

knowledge, and resources necessary to 

carry out the proposed injury research 

as outlined above is invited to work 

with their institution to develop an 

application for support. Individuals 

from underrepresented racial and ethnic 

groups as well as individuals with 

disabilities are always encouraged to 

apply for CDC programs.

Principal investigators are encouraged 

to submit only one proposal in response 

to this program announcement. With 

few exceptions (e.g., research issues 

needing immediate public health 

attention), only one application per 

principal investigator will be funded 

under this announcement. 

IV. Application and Submission 

Information 

IV.1. Address To Request Application 

Package 

To apply for this funding opportunity, 

use application form PHS 398 (OMB 

number 0925–0001 rev. 5/2001). Forms 

and instructions are available in an 

interactive format on the CDC Web site, 

at the following Internet address: http:

//www.cdc.gov/od/pgo/forminfo.htm.

Forms and instructions are also 

available in an interactive format on the 

National Institutes of Health (NIH) 

website at the following Internet 

address: http://grants.nih.gov/grants/

funding/phs398/phs398.html.

If you do not have access to the 

Internet, or if you have difficulty 

accessing the forms on-line, you may 

contact the CDC Procurement and 

Grants Office Technical Information 

Management Section (PGO–TIM) staff 

at: 770–488–2700. Application forms 

can be mailed to you. 

IV.2. Content and Form of Application 

Submission Letter of Intent (LOI) 

Your LOI must be written in the 

following format:

• Maximum number of pages: Two 

• Font size: 12-point unreduced 

• Paper size: 8.5 by 11 inches 

• Page margin size: One inch 

• Printed only on one side of page 

• Single spaced 

• Written in plain language, avoid 

jargon 

Your LOI must contain the following 

information: 

• Descriptive title of the proposed 

research 

• Name, address, email address, and 

telephone number of the Principal 

Investigator 

• Names of other key personnel 

• Participating institutions 

• Number and title of this Program 

Announcement 

• Brief description of the scope and 

intent of the proposed research work.

Application: Follow the PHS 398 

application instructions for content and 

formatting of your application. If the 

instructions in this announcement differ 

in any way from the PHS 398 

instructions, follow the instructions in 

this announcement. For further 

assistance with the PHS 398 application 

form, contact PGO–TIM staff at 770–

488–2700, or contact GrantsInfo, 

Telephone (301) 435–0714, E-mail: 

GrantsInfo@nih.gov.

You are required to have a Dun and 

Bradstreet Data Universal Numbering 

System (DUNS) number to apply for a 

grant or cooperative agreement from the 

Federal government. Your DUNS 

number must be entered on line 11 of 

the face page of the PHS 398 application 

form. The DUNS number is a nine-digit 

identification number, which uniquely 

identifies business entities. Obtaining a 

DUNS number is easy and there is no 

charge. To obtain a DUNS number, 

access http://

www.dunandbradstreet.com or call 1–

866–705–5711. For more information, 

see the CDC Web site at: http://

www.cdc.gov/od/pgo/funding/

pubcommt.htm.

This announcement uses the nonmodular budgeting format. Follow the 

PHS–398 instructions for non-modular 

budget research grant applications.

In addition to the instructions 

provided in the PHS 398 for writing the 

Description on page 2 of the PHS 398 

Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 63395

form, structure the Description using the 

following components: 

• Statement of the problem; 

• Purpose of the proposed research; 

• Methods, including study 

population, data sources and any 

statistical analyses to be performed; 

• Implications for prevention. 

The Description (abstract) should 

answer the following questions: 

• Does the Description state the 

hypothesis? 

• Does the Description describe the 

objectives and specific aims? 

• Does the Description state the 

importance of the research and how it 

is innovative? 

• Does the Description outline the 

methods that will be used to accomplish 

the goals? 

• Is the language of the Description 

simple and easy to understand for a 

broad audience? 

You must include a research plan in 

your application. The research plan 

should be no more than 15 pages, 

printed on one side, single spaced, with 

one half-inch margin, and unreduced 

12-point font. The research plan should 

address activities to be conducted over 

the entire project period. Use the 

information in the Research Objectives, 

Administrative and National Policy 

Requirements, and Application Review 

Information sections to develop the 

application content. The research plan 

should include the following 

information: 

• The project’s focus, a justification 

for the research proposed, and a 

description of the scientific basis for the 

research. The focus should be based on 

recommendations in ‘‘Healthy People 

2010’’ (http://www.healthypeople.gov)

and the ‘‘CDC Injury Research Agenda,’’

(http://www.cdc.gov/ncipc/pub-res/

research_agenda/agenda.htm) and 

should seek creative approaches that 

will contribute to a national program for 

injury control. 

• Specific, measurable, and timeframed objectives. 

• A detailed plan describing the 

methods, which will achieve the 

objectives, including their sequence. A 

comprehensive evaluation plan is an 

essential component of the application. 

• A description of the roles and 

responsibilities principal investigator. 

• A description of the involvement of 

other entities that will relate to the 

proposed project, if applicable. It should 

include commitments of support and a 

clear statement of their roles. 

• An explanation of how the research 

findings will contribute to the national 

effort to reduce the morbidity, mortality 

and disability caused by injuries within 

three to five years from project start-up. 

Additional Materials Required 

In addition to the completed PHS 398 

application form, the applicant must 

also submit the following materials, 

attached to the application as 

appendices: 

• A letter from the applicant’s mentor 

which: 

a. Fully identifies the members of the 

dissertation committee. 

b. Certifies that the mentor has read 

the application and believes that it 

reflects the work to be completed in the 

dissertation. (Letters certifying approval 

of the dissertation proposal must be 

received before negotiation and award 

of the grant.) 

c. Certification that the institution’s 

facilities and general environment are 

adequate to conduct the proposed 

research.

• A tentative time line for completion 

of the research, the dissertation, and the 

dissertation defense. 

• An official transcript of the 

applicant’s graduate school record 

showing that the applicant has 

completed all required course work for 

the degree with the exception of the 

dissertation. 

• A statement of the applicant’s 

career goals and intended career 

trajectory. 

• A biography of the mentor, limited 

to two pages (use the Biographical 

Sketch page in application form PHS 

398). 

Additional requirements that may 

require you to submit additional 

documentation with your application 

are listed in section ‘‘VI.2. 

Administrative and National Policy 

Requirements.’’

For additional help in preparing your 

grant application please see the 

‘‘frequently asked questions’’ section on 

the NCIPC Web page at: http://

www.cdc.gov/ncipc/res-opps/

2004pas.htm. 

IV.3. Submission Dates and Times 

LOI Deadline Date: December 1, 2004. 

CDC requests that you send a LOI if 

you intend to apply for this program. 

Although the LOI is not required, not 

binding, and does not enter into the 

review of your subsequent application, 

the LOI will be used to gauge the level 

of interest in this program, and to allow 

CDC to plan the application review. 

Application Deadline Date: January 

31, 2005. 

Explanation of Deadlines:

Applications must be received in the 

CDC Procurement and Grants Office 

(PGO) (not NIH) by 4 p.m. Eastern Time 

on the deadline date. If you submit your 

application by the United States Postal 

Service or commercial delivery service, 

you must ensure that the carrier will be 

able to guarantee delivery by the closing 

date and time. If CDC receives your 

submission after closing due to: (1) 

Carrier error, when the carrier accepted 

the package with a guarantee for 

delivery by the closing date and time, or 

(2) significant weather delays or natural 

disasters, you will be given the 

opportunity to submit documentation of 

the carriers guarantee. If the 

documentation verifies a carrier 

problem, CDC will consider the 

submission as having been received by 

the deadline. 

This announcement is the definitive 

guide on LOI and grant application 

content, submission address, and 

deadline. It supersedes information 

provided in the application instructions. 

If your application does not meet the 

deadline above, it will not be eligible for 

review, and will be discarded. You will 

be notified that you did not meet the 

submission requirements. 

CDC will not notify you upon receipt 

of your submission. If you have a 

question about the receipt of your LOI 

or application, first contact your courier. 

If you still have a question, contact the 

PGO–TIM staff at: 770–488–2700. Before 

calling, please wait two to three days 

after the submission deadline. This will 

allow time for submissions to be 

processed and logged. 

IV.4. Intergovernmental Review of 

Applications 

Executive Order 12372 does not apply 

to this program. 

IV.5. Funding Restrictions 

Restrictions, which must be taken into 

account while writing your budget, are 

as follows: 

• Funds relating to the conduct of 

research will not be released until the 

appropriate assurances and Institutional 

Review Board (IRB) approvals are in 

place.

• Grant funds will not be made 

available to support the provision of 

direct care including medical and/or 

psychiatric care. 

• Eligible applicants may enter into 

contracts, including consortia 

agreements, as necessary to meet the 

requirements of the program and 

strengthen the overall application. 

• Allowable costs include partial 

salary support for the applicant; such as 

interviewer expenses, data processing, 

participant incentives, statistical 

consultant services, supplies, 

dissertation printing costs, and travel to 

one scientific meeting, if adequately 

justified. 

63396 Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 

• Applicants should also include 

travel costs for one, two-day trip to CDC 

in Atlanta to present research findings. 

• Indirect costs for this trainee-related 

grant are limited to eight percent. 

If you are requesting indirect costs in 

your budget, you must include a copy 

of your indirect cost rate agreement. If 

your indirect cost rate is a provisional 

rate, the agreement should be less than 

12 months of age. 

IV.6. Other Submission Requirements 

LOI Submission Address: Submit your 

LOI by express mail, delivery service, 

fax, or E-mail to: NCIPC Extramural 

Resources Team, Centers for Disease 

Control and Prevention, National Center 

for Injury Prevention and Control, 4770 

Buford Hwy, NE, Mailstop K–62, 

Atlanta, GA 30341, Telephone: 770–

488–4037, Fax: 770–488–1662, E-mail: 

CIPERT@CDC.GOV. 

Application Submission Address:

Submit the original and one hard copy 

of your application by mail or express 

delivery service to: Technical 

Information Management—CE05–025, 

CDC Procurement and Grants Office, 

2920 Brandywine Road, Atlanta, GA 

30341. 

At the time of submission, four 

additional copies of the application, and 

four copies of all appendices must be 

sent to: NCIPC Extramural Resources 

Team, CDC, National Center for Injury 

Prevention and Control, Address for 

Express Mail or Delivery Service: 2945 

Flowers Road, Yale Building, Room 

2054, Atlanta, Georgia 30341. Address 

for U.S. Postal Service Mail: 4770 

Buford Hwy, NE, Mailstop K–62, 

Atlanta, GA 30341. 

Applications may not be submitted 

electronically at this time. 

V. Application Review Information 

V.1. Criteria 

Applicants are required to provide 

measures of effectiveness that will 

demonstrate the accomplishment of the 

various identified objectives of the 

grant. Measures of effectiveness must 

relate to the performance goals stated in 

the ‘‘Purpose’’ section of this 

announcement. Measures must be 

objective and quantitative, and must 

measure the intended outcome. These 

measures of effectiveness must be 

submitted with the application and will 

be an element of evaluation.

The goals of CDC-supported research 

are to improve the control and 

prevention of disease and injury and to 

enhance health. In the written 

comments, reviewers will be asked to 

evaluate the application in order to 

judge the likelihood that the proposed 

research will have a substantial impact 

on the pursuit of these goals. 

The scientific review group will 

address and consider each of the 

following criteria equally in assigning 

the application’s overall score, 

weighting them as appropriate for each 

application. The application does not 

need to be strong in all categories to be 

judged likely to have major scientific 

impact and thus deserve a high priority 

score. For example, an investigator may 

propose to carry out important work 

that by its nature is not innovative, but 

is essential to move a field forward. 

The review criteria are as follows: 

Significance: Does this study address 

an important problem? If the aims of the 

application are achieved, how will 

scientific knowledge be advanced? What 

will be the effect of these studies on the 

concepts or methods that drive this 

field? 

Approach: Are the conceptual 

framework, design, methods, and 

analyses adequately developed, well 

integrated, and appropriate to the aims 

of the project? Does the applicant 

acknowledge potential problem areas 

and consider alternative tactics? Does 

the project include plans to measure 

progress toward achieving the stated 

objectives? Is there an appropriate work 

plan included? 

Innovation: Does the project employ 

novel concepts, approaches or methods? 

Are the aims original and innovative? 

Does the project challenge existing 

paradigms or develop new 

methodologies or technologies? 

Investigator: Is the investigator 

appropriately trained and well suited to 

carry out this work? Is the work 

proposed appropriate to the experience 

level of the principal investigator and 

other researchers (if any)? Is there a 

prior history of conducting injuryrelated research? 

Environment: Does the scientific 

environment in which the work will be 

done contribute to the probability of 

success? Do the proposed experiments 

take advantage of unique features of the 

scientific environment or employ useful 

collaborative arrangements? Is there 

evidence of institutional support? Is 

there an appropriate degree of 

commitment and cooperation of other 

interested parties as evidenced by letters 

detailing the nature and extent of the 

involvement? 

Additional Review Criteria: In 

addition to the above criteria, the 

following items will be considered in 

the determination of scientific merit and 

priority score: 

Dissemination: What plans have been 

articulated for disseminating findings? 

Protection of Human Subjects from 

Research Risks: Does the application 

adequately address the requirements of 

Title 45 CFR Part 46 for the protection 

of human subjects? This will not be 

scored; however, an application can be 

disapproved if the research risks are 

sufficiently serious and protection 

against risks is so inadequate as to make 

the entire application unacceptable.

Inclusion of Women and Minorities in 

Research: Does the application 

adequately address the CDC Policy 

requirements regarding the inclusion of 

women, ethnic, and racial groups in the 

proposed research? This includes: (1) 

The proposed plan for the inclusion of 

both sexes and racial and ethnic 

minority populations for appropriate 

representation; (2) The proposed 

justification when representation is 

limited or absent; (3) A statement as to 

whether the design of the study is 

adequate to measure differences when 

warranted; and (4) A statement as to 

whether the plans for recruitment and 

outreach for study participants include 

the process of establishing partnerships 

with community (ies) and recognition of 

mutual benefits. 

Inclusion of Children as Participants 

in Research Involving Human Subjects:

The NIH maintains a policy that 

children (i.e., individuals under the age 

of 21) must be included in all human 

subjects research, conducted or 

supported by the NIH, unless there are 

scientific and ethical reasons not to 

include them. This policy applies to all 

initial (Type 1) applications submitted 

for receipt dates after October 1, 1998. 

NCIPC has adopted this policy for this 

announcement. 

All investigators proposing research 

involving human subjects should read 

the ‘‘NIH Policy and Guidelines’’ on the 

inclusion of children as participants in 

research involving human subjects that 

is available at http://grants.nih.gov/

grants/funding/children/children.htm.

Budget: The reasonableness of the 

proposed budget and the requested 

period of support in relation to the 

proposed research. 

V.2. Review and Selection Process 

Applications will be reviewed for 

completeness by the PGO and for 

responsiveness by NCIPC. Incomplete 

applications and applications that are 

non-responsive to the eligibility criteria 

will not advance through the review 

process. Applicants will be notified that 

their application did not meet 

submission requirements. 

Applications that are complete and 

responsive to the announcement will be 

evaluated for scientific and technical 

merit by an appropriate peer review 

Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 63397

panel convened by the NCIPC in 

accordance with the review criteria 

listed above. As part of the initial merit 

review, all applications will: 

• Undergo a process in which only 

those applications deemed to have the 

highest scientific merit by the review 

group, generally the top half of the 

applications under review, will be 

discussed and assigned a priority score. 

• Receive a written critique. 

The primary review will be a peer 

review conducted by NCIPC Initial 

Review Group (IRG). Applications may 

be subjected to a preliminary evaluation 

(streamline review) by the IRG to 

determine if the application is of 

sufficient technical and scientific merit 

to warrant further review. NCIPC will 

withdraw from further consideration 

applications judged to be 

noncompetitive and promptly notify the 

principal investigator/program director 

and the official signing for the applicant 

organization. Those applications judged 

to be competitive will be further 

evaluated by the IRG. These 

applications will be reviewed for 

scientific merit using current NIH 

criteria (a scoring system of 100–500 

points) to evaluate the methods and 

scientific quality of the application. 

The secondary review will be 

conducted by the Science and Program 

Review Subcommittee (SPRS) of the 

Advisory Committee for Injury 

Prevention and Control (ACIPC). The 

ACIPC Federal agency experts will be 

invited to attend the secondary review 

and will receive modified briefing books 

(i.e., abstracts, strengths and weaknesses 

from summary statements, and project 

officer’s briefing materials). ACIPC 

Federal agency experts will be 

encouraged to participate in 

deliberations when applications address 

overlapping areas of research interest, so 

that unwarranted duplication in 

Federally-funded research can be 

avoided and special subject area 

expertise can be shared. The NCIPC 

Division Associate Directors for Science 

(ADS) or their designees will attend the 

secondary review in a similar capacity 

as the ACIPC Federal agency experts to 

assure that research priorities of the 

announcement are understood and to 

provide background regarding current 

research activities. Only SPRS members 

will vote on funding recommendations, 

and their recommendations will be 

carried to the entire ACIPC for voting by 

the ACIPC members in closed session. If 

any further review is needed by the 

ACIPC, regarding the recommendations 

of the SPRS, the factors considered 

would be the same as those considered 

by the SPRS.

The ACIPC committee’s responsibility 

is to develop funding recommendations 

for the NCIPC Director based on the 

results of the primary review, the 

relevance and balance of proposed 

research relative to the NCIPC programs 

and priorities, and to assure that 

unwarranted duplication of federallyfunded research does not occur. The 

secondary review committee has the 

latitude to recommend to the NCIPC 

Director to reach over better-ranked 

proposals in order to assure maximal 

impact and balance of proposed 

research. The factors to be considered 

will include: 

• The results of the primary review 

including the application’s priority 

score as the primary factor in the 

selection process. 

• The relevance and balance of 

proposed research relative to the NCIPC 

programs and priorities. 

• The significance of the proposed 

activities in relation to the priorities and 

objectives stated in ‘‘Healthy People 

2010,’’ the Institute of Medicine report, 

‘‘Reducing the Burden of Injury,’’ and 

the ‘‘CDC Injury Research Agenda.’’ (See 

Attachment 1, Resource Materials. The 

attachment is posted along with this 

announcement on the CDC Web site: 

http://www.cdc.gov/ncipc/

ncipchm.htm.) 

• Budgetary considerations. 

All awards will be determined by the 

Director of the NCIPC based on priority 

scores assigned to applications by the 

primary review committee IRG, 

recommendations by the secondary 

review committee of the Science and 

Program Review Subcommittee of the 

ACIPC, consultation with NCIPC senior 

staff, and the availability of funds. 

Award Criteria: Criteria that will be 

used to make award decisions during 

the programmatic review include: 

• Scientific merit (as determined by 

peer review); 

• Availability of funds; 

• Programmatic priorities; 

V.3. Anticipated Announcement and 

Award Dates 

August 30, 2005 

VI. Award Administration Information 

VI.1. Award Notices 

Successful applicants will receive a 

Notice of Grant Award (NGA) from the 

CDC Procurement and Grants Office. 

The NGA shall be the only binding, 

authorizing document between the 

recipient and CDC. The NGA will be 

signed by an authorized Grants 

Management Officer, and mailed to the 

recipient fiscal officer identified in the 

application. 

Unsuccessful applicants will receive 

notification of the results of the 

application review by mail. 

VI.2. Administrative and National 

Policy Requirements 

45 CFR Part 74 and Part 92. 

For more information on the Code of 

Federal Regulations, see the National 

Archives and Records Administration at 

the following Internet address: http://

www.access.gpo.gov/nara/cfr/cfr-tablesearch.html.

The following additional 

requirements apply to this project: 

• AR–1 Human Subjects 

Requirements 

• AR–2 Requirements for Inclusion 

of Women and Racial and Ethnic 

Minorities in Research 

• AR–3 Animal Subjects 

Requirements 

• AR–9 Paperwork Reduction Act 

Requirements 

• AR–10 Smoke-Free Workplace 

Requirements 

• AR–11 Healthy People 2010 

• AR–12 Lobbying Restrictions 

• AR–13 Prohibition on Use of CDC 

Funds for Certain Gun Control 

Activities

• AR–21 Small, Minority, and 

Women-Owned Business 

• AR–22 Research Integrity 

Additional information on AR–1 

through AR–22 can be found on the 

CDC Web site at the following Internet 

address: http://www.cdc.gov/od/pgo/

funding/ARs.htm.

• AR–25 Release and Sharing of 

Data 

Starting with the December 1, 2003 

receipt date, all ‘‘Requests for 

Applications (RFA)/Program 

Announcements (PA)’’ soliciting 

proposals for individual research 

projects of $500,000 or more in total 

(direct and indirect) costs per year 

require the applicant to include a plan 

describing how the final research data 

will be shared/released or explain why 

data sharing is not possible. Details on 

data sharing and release, including 

information on the timeliness of the 

data and the name of the project data 

steward, should be included in a brief 

paragraph immediately following the 

‘‘Research Plan’’ section of the PHS 398 

form. References to data sharing and 

release may also be appropriate in other 

sections of the application (e.g.

background and significance, or human 

subjects requirements). The content of 

the data sharing and release plan will 

vary, depending on the data being 

collected and how the investigator is 

planning to share the data. The data 

sharing and release plan will not count 

toward the application page limit and 

63398 Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 

will not factor into the determining 

scientific merit or the priority scoring. 

Investigators should seek guidance from 

their institutions on issues related to 

institutional policies, and local IRB 

rules, as well as local, state and federal 

laws and regulations, including the 

Privacy Rule. 

Further detail on the requirements for 

addressing data sharing in applications 

for NCIPC funding may be obtained by 

contacting NCIPC program staff or by 

visiting the NCIPC Internet: at http://

www.cdc.gov/ncipc/osp/

sharing_policy.htm.

VI.3. Reporting 

You must provide CDC with an 

original, plus two hard copies of the 

following reports: 

1. Financial status report, no more 

than 90 days after the end of the budget 

period. 

2. The final performance report, no 

more than 90 days after the end of the 

project period. The final performance 

report will be a brief summary (2,500 to 

4,000 words in length) written in nonscientific [laymen’s] terms. The report 

should highlight the findings and their 

implications for injury prevention 

programs, policies, environmental 

changes, etc. The grant recipient will 

also include a description of the 

dissemination plan for research 

findings. This plan will include 

publications in peer-reviewed journals 

and ways in which research findings 

will be made available to stakeholders 

outside of academia (e.g., state injury 

prevention program staff, community 

groups, public health injury prevention 

practitioners, and others). CDC will 

place the summary report and each 

grant recipient’s final report with the 

National Technical Information Service 

(NTIS) to further the agency’s efforts to 

make the information more available 

and accessible to the public. 

These reports must be mailed to the 

Grants Management Specialist listed in 

the ‘‘Agency Contacts’’ section of this 

announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement.

For general questions, contact: 

Technical Information Management 

Section, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341, Telephone: 770–488–2700. 

For scientific/research issues, contact: 

Paul Smutz, Project Officer, Office of the 

Director, National Center for Injury 

Prevention and Control, Centers for 

Disease Control and Prevention (CDC), 

4770 Buford Highway, NE., Mailstop K–

02, Atlanta, GA 30341, Telephone: 770–

488–1508, E-mail: pos1@cdc.gov.

For questions about peer review, 

contact: Gwendolyn Cattledge, 

Scientific Review Administrator, 

Associate Director for Extramural 

Research, National Center for Injury 

Prevention and Control, Centers for 

Disease Control and Prevention (CDC) 

4770 Buford Highway, NE., Mailstop K–

02, Atlanta, GA 30341, Telephone: 770–

488–1430, E-mail: gxc8@cdc.gov.

For financial, grants management, or 

budget assistance, contact: Pamela 

Render, Grants Management Specialist, 

CDC Procurement and Grants Office, 

2920 Brandywine Road, Atlanta, GA 

30341, Telephone: 770/488–2712, Email: PLR3@cdc.gov.

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

Dated: October 21, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–24027 Filed 10–29–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Notice of Lien. 

OMB No.: 0970–0153. 

Description: Section 452(a)(11) of the 

Social Security Act requires the 

Secretary of Health and Human Services 

to promulgate a form for the imposition 

of liens to be used by State child 

support enforcement programs for 

enforcement of support orders in 

interstate cases. Section 454(9)(E) of the 

Social Security Act requires each State 

to cooperate with any other State in 

using the Federal form for imposition of 

liens in interstate child support cases. 

Tribes are not required to use this form 

but many choose to do so. 

Responders: State, local, or Tribal 

agencies administering a child support 

enforcement program under Title IV–D 

of the Social Security Act.

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses 

per respondent 

Average 

burden 

hours per 

response 

Total burden hours 

Notice of Lien ................................................................................................................... 109,384 1 .25 27,346

Estimated Total Annual Burden 

Hours: 27,346. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

grjohnson@acf.hhs.gov.

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Attn: Desk Officer for 

ACF, e-mail address: 

Katherine_T._Astrich@omb.eop.gov.

Dated: October 25, 2004. 

Robert Sargis, 

Reports Clearance Officer.

[FR Doc. 04–24276 Filed 10–29–04; 8:45 am] 

BILLING CODE 4184–01–M